Discover
ABVC
ABVC BioPharma, Inc.
1.16
2 x 0.79
2 x 1.30
bid
ask
+
0.01
0.87%
2 @ 04:04 AM
1.35 +0.19 (16.38%)
| Ytd | -45.54% | |
| 1y | -57.35% |
1.11
day range
1.21
0.71
52 week range
3.40
| Open | 1.15 | Prev Close | 1.15 | Low | 1.11 | High | 1.21 | Mkt Cap | 30.92M |
| Vol | 199.57K | Avg Vol | 142.18K | EPS | -0.29 | P/E | N/A | Forward P/E | -1.16 |
| Beta | 0.82 | Short Ratio | 0.70 | Inst. Own | 3.01% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.03 | 200-d Avg | 1.44 | 1yr Est | 2.02 |
| Income Statement | |||
| Operating Expenses | 779.53K | ||
| Research and Development Expense | 22.71K | ||
| Selling, General and Administrative Expense | 503.78K | ||
| Operating Income | -779.53K | ||
| Interest Expense | 42.32K | ||
| Net Income | -736.93K | ||
| Net Income Common Stock | -736.93K | ||
| Net Income Common Stock (USD) | -736.93K | ||
| Consolidated Income | -810.48K | ||
| Net Income to Non-Controlling Interests | -73.55K | ||
| Earnings per Basic Share | -0.03 | ||
| Earnings per Basic Share (USD) | -0.03 | ||
| Earnings per Diluted Share | -0.03 | ||
| Earning Before Interest & Taxes (EBIT) | -694.61K | ||
| Earning Before Interest & Taxes (USD) | -694.61K | ||
| Weighted Average Shares | 26.06M | ||
| Weighted Average Shares Diluted | 26.06M | ||
| Balance Sheet | |||
| Cash and Equivalents | 31.94K | ||
| Cash and Equivalents (USD) | 31.94K | ||
| Investments | 2.58M | ||
| Investments Current | 91.88K | ||
| Investments Non-Current | 2.49M | ||
| Trade and Non-Trade Receivables | 136.34K | ||
| Current Assets | 411.73K | ||
| Property, Plant & Equipment Net | 14.58M | ||
| Total Assets | 19.40M | ||
| Debt Current | 1.22M | ||
| Total Debt | 2.62M | ||
| Current Liabilities | 5.69M | ||
| Debt Non-Current | 1.41M | ||
| Total Liabilities | 7.13M | ||
| Accumulated Retained Earnings (Deficit) | -79.16M | ||
| Accumulated Other Comprehensive Income | 498.19K | ||
| Shareholders Equity | 10.29M | ||
| Shareholders Equity (USD) | 10.29M | ||
| Assets Non-Current | 18.99M | ||
| Total Debt (USD) | 2.62M | ||
| Deferred Revenue | 12.60K | ||
| Deposit Liabilities | 31.17K | ||
| Liabilities Non-Current | 1.44M | ||
| Trade and Non-Trade Payables | 265.30K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 89.50K | ||
| Net Cash Flow from Financing | 226.21K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -108.38K | ||
| Net Cash Flow - Business Acquisitions and Disposals | -145.13K | ||
| Issuance (Repayment) of Debt Securities | -29.65K | ||
| Net Cash Flow from Investing | -101.53K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 43.60K | ||
| Net Cash Flow from Operations | -244.41K | ||
| Effect of Exchange Rate Changes on Cash | 11.36K | ||
| Share Based Compensation | 253.04K | ||